FAM107B

Across TCGA pan-cancer cohorts, FAM107B Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated FAM107B data layer compared with 24 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher FAM107B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FAM107B expression acts as an unfavorable survival marker.

HNSC, LIHC, and SCLC are the cancer types where FAM107B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.081	0.768	<.001	48	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	12	view →
SCLC	OS	Median	All	0.219	0.706	.011	6	view →
UCEC	OS	Median	IV	0.232	0.608	.006	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

FAM107B–HNSC (OS)

Open the HNSC breakdown →